CHOP Alone Compared With CHOP Plus Radiotherapy for Localized Aggressive Lymphoma in Elderly Patients: A Study by the Groupe d’Etude des Lymphomes de l’Adulte Fludarabine and cyclophosphamide produced ...

Bendamustine in Patients With Rituximab-Refractory Indolent and Transformed Non-Hodgkin's Lymphoma: Results From a Phase II Multicenter, Single-Agent Study Fifty patients were treated (20 patients had ...

Please provide your email address to receive an email when new articles are posted on . “Fifteen percent of [patients with B-cell ALL] are primary refractory or relapse after initial treatment, but ...

Adaptimmune ($ADAP) has responded to the failure of its T-cell therapy to induce objective clinical responses in ovarian cancer patients by adding fludarabine--the ...

Please provide your email address to receive an email when new articles are posted on . SALT LAKE CITY — Treosulfan plus fludarabine conditioning after allogeneic hematopoietic stem cell ...

We hypothesized that judicious use of pharmacokinetic (PK) information to guide/individualize Bu delivery would compensate for inter-individual variability in drug handling and metabolism. This ...

To earn CME related to this news article, click here. January 9, 2009 — The US Food and Drug Administration (FDA) has approved fludarabine phosphate tablets for the treatment of B-cell chronic ...

All patients receiving ⩾1 cycle of therapy were evaluable for response and treatment responses were determined according to NCI-WG criteria. The primary efficacy end point was the overall response ...

GRAFAPEX™ (treosulfan) with fludarabine is FDA-approved for AML and MDS patients undergoing alloHSCT, showing improved overall survival compared to busulfan. Common side effects include ...

Fludarabine phosphate is the third drug to receive label changes under this program. The Food and Drug Administration (FDA) approved updated drug labeling for fludarabine phosphate (Fludarabine ...